English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Shire
Nicholas Gueguen
| Jun 30, 2017
Shire study sees reduction in hereditary angioedema episodes using lanadelumab
Ruth de Jauregui
| May 3, 2017
Study indicates one bleeding incident every 3-15 seconds among hemophiliacs
Robert Hadley
| Apr 28, 2017
Shire’s hashtag campaign focusing on primary immunodeficiency
Keri Carbaugh
| Feb 6, 2017
Shire takes lead on rare conditions, CEO says
Keri Carbaugh
| Jan 18, 2017
Shire again offers scholarship for students with ADHD
Amanda Rupp
| Jun 11, 2016
Shire shareholders approve Baxalta merger
Amanda Rupp
| Jun 7, 2016
CHMP gives positive opinion of short bowl syndrome pediatric medicine
Amanda Rupp
| Apr 17, 2016
Shire sends application to FDA for chewable Vyvanse tablets
Trending
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
Patient Daily
| Sep 19, 2025
ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’
